Shots:

• Sanofi inaugurates its first digitally enabled- continuous manufacturing facility in Framingham- Massachusetts- marking one of the world’s first digital facilities utilizing intensified- continuous biologics production technology and will manufacture biologics for the Specialty Care portfolio
• The focus of the digital manufacturing facility is to leverage better use of data to optimize the company’s manufacturing processes- increasing efficiencies and speeding up the commercialization of new therapies emerging from the R&D pipeline
• The digital bio-manufacturing facility is a part of Sanofi’s integrated biologics hub in Framingham and utilizes paperless and data-driven manufacturing technologies. Sanofi has successfully completed its process qualification runs in Q3’19

Click here to­ read full press release/ article | Ref: Sanofi | Image: Dalal Street